Lilly(Eli) & Co (LLY) Stock Price, Graph, News & Analysis

Manufacturing (Pharmaceutical Preparation Manufacturing ) | NEW YORK STOCK EXCHANGE INC. : LLY

$243.75 $2.58 (1.07%)

Market Status : Closed
Last Update : 10/22/2021 4:02:45 PM

LLY

Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world. It was founded more than a century ago by a man committed Read More

Historical Price Graph

Performance

1 Month 3 Month 6 Month YTD 1 Year 3 Year 5 Year
4.78% 1.96% 27.27% 44.53% 73.58% 132.01% 244.42%

Details

Exchange
NEW YORK STOCK EXCHANGE INC.

Industry
Pharmaceutical Preparation Manufacturing

Website
www.lilly.com

Sector
Manufacturing

CEO
David Ricks

Total Employees
2,020

SIC Code
2834

Market Cap
$ 233.76 B

Key Statistics

Dividend Rate
$3.27

Last Dividend
2021-08-12

Dividend Yield
1.36%

P/E Ratio
36.65

Price Range (52 Week)
$127.04 - $275.87

Latest Volume
$ 1.96 M

Average Total Volume
$ 2.48 M

Outstanding Shares
959,025,446

Beta
60.22%

Similar Stocks

CompanySectorLatest PriceChange
Cisco Systems, Inc. (CSCO) Technology Services $55.11 -$0.58
Accenture plc - Class A (ACN) Technology Services $353.79 $6.67
Abbott Laboratories (ABT) Health Technology $126.72 $1.67
Danaher Corp. (DHR) Health Technology $313.38 $2.64
PepsiCo Inc (PEP) Consumer Non-Durables $159.97 $0.79

Lilly(Eli) & Co in News

Intrado Digital Media (APLS,LLY,NVO)
Worldwide Peptide Therapeutics Industry to 2030 - Featuring Apellis Pharmaceuticals, Eli Lilly and Novo Nordisk Among Others Dublin, July 08, 2021 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market by Type of Peptide, Route
Jul 8, 2021 7:43 AM

Business Wire (LLY)
Verge Genomics Announces Three-Year Collaboration With Lilly to Discover and Develop Novel Treatments Using Its AI-Driven All-in-Human Platform SAN FRANCISCO--(BUSINESS WIRE)--Verge Genomics, a biotech company that has created an industry leadi
Jul 8, 2021 6:30 AM

PR Newswire Asia (English) (UCB-BB,UCBJY,SOLB-BB,SVYSF,SOLVY,SOL-GD,SOL-GF,SOL-GM,SOL-GS,SOL-GB,LLY,ABBV)
BioShin Expands Senior Leadership Team: Sarah Lu Joins BioShin as Chief Medical Officer, Mary Ma Joins BioShin as Chief Commercial Officer SHANGHAI , July 8, 2021 /PRNewswire/ -- BioShin Limited today announced the appointment of Dr. Zhiho
Jul 8, 2021 12:01 AM

Tramways Monthly (ESALY,ESALF,LLY,BIIB,OSUKF,MRK-GY,MRK-GH,MRK-GD,MRK-GF,MRK-GM,MRK-GS,MRK-GI,MRK-GB,MKGAF,MKKGY)
Cancer Treatment Drugs Market Will Touch New Level in Upcoming Year by Eisai, Eli Lilly, Biogen Idec, Otsuka, Merck KGaA Cancer Treatment Drugs Market research is an intelligence report with meticulous efforts undertaken
Jul 7, 2021 4:48 PM

BioWorld (LLY)
Eli Lilly and Company synthesizes GTPase KRAS mutant inhibitors No summary available.
Jul 7, 2021 9:58 AM

MedCity News (LLY)
Eli Lilly''s $15M investment deepens link to startup developing new class of RNA meds - MedCity News Two months after Eli Lilly began an alliance with MiNA Therapeutics, a startup developing a new type
Jul 6, 2021 7:07 PM

Benzinga (LLY)
Eli Lilly, Boehringer Ingelheim Tout Heart Failure Win For Jardiance Boehringer Ingelheim and Eli Lilly And Co (NYSE: LLY ) have announced the topline results from the E
Jul 6, 2021 2:18 PM

FiercePharma (LLY)
Eli Lilly, Boehringer Ingelheim''s Jardiance posts ''blockbuster'' heart failure win, setting up 2021 filings Eli Lilly, Boehringer Ingelheim''s Jardiance posts ''blockbuster'' heart failure win, setting up 202
Jul 6, 2021 11:28 AM

Benzinga (LLY)
Lilly Invests In MiNA To Fund Protein-Upregulating RNA Programs Eli Lilly And Co (NYSE: LLY ) is set to invest $15 million in its small activating RNA (saRNA) partn
Jul 6, 2021 11:06 AM

Endpoints News (LLY)
Eli Lilly adds a $15M equity sweetener for its platform partner in saRNA The father-and-son team at MiNA Therapeutics is on a roll. Just weeks after snagging a $25 million u
Jul 6, 2021 9:40 AM

Common Questions Related to Lilly(Eli) & Co

When is Lilly(Eli) & Co next earning date?

Lilly(Eli) & Co next earning date is 2021-10-26

What is dividend yield of Lilly(Eli) & Co stock?

Lilly(Eli) & Co dividend yield is 0.013567691983339583 and Lilly(Eli) & Co announced last dividend in 2021-08-12 of amount $3.27/stock.

What is Lilly(Eli) & Co stock symbol?

Lilly(Eli) & Co traded in NEW YORK STOCK EXCHANGE INC. stock exchange and the stock symbol/ticker is LLY

What is the latest share price of Lilly(Eli) & Co (LLY)? or What is Lilly(Eli) & Co stock price today?

Lilly(Eli) & Co latest stock price is $243.75

Where is Lilly(Eli) & Co headquarter?

Lilly(Eli) & Co headquarter is at – Lilly Corporate Ctr, Indianapolis, Indiana, US

What is the total market cap of Lilly(Eli) & Co company?

The total market value of Lilly(Eli) & Co stock is $ 231.29 B

What is the P/E ratio of Lilly(Eli) & Co stock?

Lilly(Eli) & Co P/E ratio is 38.09909348375311

What is the EPS of Lilly(Eli) & Co stock?

Lilly(Eli) & Co EPS is 6.65

What is the Beta of Lilly(Eli) & Co stock?

Lilly(Eli) & Co Beta is 0.6022258616991446

Related Tags

Lilly(Eli) & Co stock price history, Lilly(Eli) & Co stock quote, LLY current stock price, Lilly(Eli) & Co dividend yield, Lilly(Eli) & Co Dividend, How much is Lilly(Eli) & Co worth